Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
26.04.23
-
26.04.24
-
27.04.24

StockNews.com 
26.04.23 50%
sell
Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
26.04.23
-
26.04.24
-
27.04.24

StockNews.com 
26.04.23 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€30.42
26.04.23
€72.10
26.04.24
-32.54%
27.04.24

Sumitomo Mitsui Financial Group, Inc. 
26.04.23 50%
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€40.90
26.04.23
-
26.04.24
5.13%
27.04.24

melinda 
26.04.23 50%
buy
Masimo Corp.

Start price
Target price
Perf. (%)
€172.00
26.04.23
-
26.04.24
-26.60%
27.04.24

Shooter 
26.04.23 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
26.04.23
-
26.04.24
-89.67%
27.04.24

kugelmann 
26.04.23 0%
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€10.85
23.04.24
€15.00
23.04.25
-2.67%
27.04.24

skatcup 
23.04.24 90%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.68
23.04.24
-
23.04.25
-15.22%
27.04.24

me8 
23.04.24 0%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€3.80
13.04.24
€2.00
13.04.25
-56.58%
27.04.24

mixitrader 
13.04.24 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€199.00
25.04.23
€307.07
25.04.24
-43.41%
26.04.24

Royal Bank of Canada 
25.04.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€79.62
24.04.23
-
24.04.24
-6.05%
25.04.24

Barclays PLC 
24.04.23 50%
buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€259.70
24.04.23
€256.65
24.04.24
13.79%
25.04.24

Stephens 
24.04.23 50%
buy
Geron Corp.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€3.63
24.04.24
37.50%
25.04.24

Needham & Company LLC 
24.04.23 50%
buy
Heron Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.40
24.04.23
€6.35
24.04.24
-5.00%
25.04.24

Needham & Company LLC 
24.04.23 50%
sell
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€25.75
23.04.23
-
23.04.24
7.50%
24.04.24

Lucius 
23.04.23 0%
sell
Trevena Inc.

Start price
Target price
Perf. (%)
€0.82
23.04.23
-
23.04.24
-60.39%
24.04.24

StockNews.com 
23.04.23 50%
sell
BioLase Inc.

Start price
Target price
Perf. (%)
€0.20
22.04.23
-
22.04.24
-66.41%
23.04.24

StockNews.com 
22.04.23 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.21
22.04.23
-
22.04.24
-22.38%
23.04.24

StockNews.com 
22.04.23 50%
sell
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€1.32
22.04.23
-
22.04.24
127.27%
23.04.24

StockNews.com 
22.04.23 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.51
22.04.23
-
22.04.24
-66.04%
23.04.24

StockNews.com 
22.04.23 50%
sell
Delcath Systems, Inc.

Start price
Target price
Perf. (%)
-
22.04.23
-
22.04.24
-
23.04.24

StockNews.com 
22.04.23 50%